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In this study, the electro-oxidative behaviour and determination of itraconazole at a glassy carbon electrode have been 
investigated using cyclic voltammetry, differential pulse anodic stripping voltammetry (DPASV), and square wave anodic stripping 
voltammetric (SWASV) techniques, under different experimental conditions. The voltammetric peak current for the oxidation of 
itraconazole has been analyzed at different pH, scan rate and concentrations. The voltammograms have exhibited irreversible 
oxidation of ITRA in B.R. buffer of pH 3.0. The oxidation of itraconazole gives a well-defined irreversible peak at glassy carbon 
electrode vs. Ag/AgCl as reference electrode. The oxidation process is adsorption controlled. A linear response has been obtained 
between 26.7×10–6 to 152.8×10–6 M in non-aqueous media for all the techniques. The analyzed square wave anodic voltammetric 
and differential pulse anodic stripping voltammetric methods show limit of detection at 27.28 µM and 65.16 µM respectively. 
Ultimately, the proposed validated method has been effectively applied for the determination of the antifungal drug which is 
commercially available in solid form. 
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The azoles are the best source of synthetic antifungal 
agents. Itraconazole is an orally administered triazole 
antifungal agent. The mechanism of action of this 
compound is the inhibition of lanosterol demethylase, a 
cytochrome P-450 enzyme
1,2






 as shown in
Figure 1. Itraconazole is a food and drug administration
approved antifungal-drug that has a history of use in
clinical trials for the cure of various diseases
5-8
. Also,
itraconazole is more effective only at low pH and
almost insoluble in water.
Various methods are already developed for the 








, and chromatographic (HPLC, 
LC-MS)
14-27
, solid state NMR
28
 and voltammetric 
techniques
29-33
 using different electrocatalysts. 
In the recent era, voltammetric techniques are used 
to determine pharmaceutical drug moieties as these 
methods provide easy handling, smoothness, portability 
and short examine time. Modern electroanalytical 
techniques, for instance square wave voltammetry 
(SWV) and differential pulse voltammetry (DPV) with 
stripping mode, are utilized for the sensitive and rapid 
plus effortless investigations of a wide range of drug 
moieties. Moreover, the stripping voltammetry is an 
excellent technique and insensitive to matrix effects
4
. 
In this report, the electrochemical behavior of 
itraconazole was studied using cyclic voltammetry in 
acidic BR buffer of pH 3 as supporting electrolyte. Also 
detection of traces amount of itraconazole by differential 
pulse anodic stripping voltammetry (DPASV) and square 
wave anodic stripping voltammetry (SWASV) at GCE. 
The procedures did not require sample pre-treatment/time 
consuming extraction. To best of our knowledge, the 
electrochemical determination of itraconazole at glassy 
carbon electrode is not exactly reported through this 
procedure and experimental conditions. 
Materials and methods 
Reagents and instrumentation 
Itraconazole was purchased from local pharmacy 
under the trade name GALITRA-200 mg and was 
used without purification. Every day, a fresh stock 
standard solution of bulk itraconazole (2.7 mM 
Figure 1 — Chemical structure of itraconazole 




concentration) was prepared in dimethylsulfoxide 
(DMSO) solvent in appropriate ratio. The buffer 
(Britton Robinson, citrate, and acetate) solutions were 
prepared and optimized 0.04M BR buffer was used as 
a supporting electrolyte. Double distilled water 
(DDW) was used to prepare the solutions and all the 
reagents used were of analytical grade. 
Electrochemical measurements were employed 
using Model 1230A/SR 400 electrochemical analyzer 
(CHI Instrument TX, USA), with a totally automated 
attached computer with proper CHI 100W version 2.3 
software for total control of the experiments, data 
compilation and treatment. A three electrode cell was 
used with GCE as working electrode for the 
voltammetric experiments. The calculated active-
surface area of GCE is 0.0882 cm
2
, as explained in our 
earlier report
34
. The platinum wire as counter electrode 
and Ag/AgCl (1M KCl) as reference electrode were 
used. Moreover, a digital pH-meter (CHINO-DB-1011) 
fitted with a glass-electrode was standardized with 
buffers of known pH and used for measuring the pH 
values of the solutions. 
 
Analytical procedure 
Initially, the GC-electrode surface was polished 
thoroughly with 0.5 μm alumina; additionally it was 
cleaned in ultrasonic-bath prior to each measurement, 
and then gently cleaned with a µ-fibered tissue paper. 
Britton Robinson buffer of pH 3.0 with KCl solution 
and the appropriate concentration of the itraconazole 
were introduced into the electrochemical cell. And the 
solution was purged with pure deoxygenated N2-gas 
for ~10 min under stirred condition for removal 
oxygen gas inside the cell, before measurements. 
Electrochemical pre-treatment was always performed 
in the same solution in which the measurement was 
subsequently carried out. After optimization of 
operational parameters the cyclic and stripping 
voltammograms were recorded. 
 
Optimization of buffer 
Various buffers including BR, citrate, and acetate 
buffers were prepared and comparatively studied for 
optimization with 2.7 mM itraconazole using DPASV 
technique, at an arbitrarily selected pH for all buffer 
solutions. It was found that BR buffer was suitable for 
electrochemical study of itraconazole as the peak 
current response is highest, as shown in Figure 2. 
 
Results and Discussion 
Electrochemical analysis of 2.7 mM itraconazole 
were performed by using cyclic voltammograms 
(CVs), differential pulse anodic stripping 
voltammograms (DPASVs), and square wave anodic 
stripping voltammograms (SWASVs). In all 
electrochemical methods itraconazole gave one well-
defined oxidation peak over the potential range 0.2 to 
1.0 V. vs. Ag/AgCl reference electrode, in BR buffer of 
pH 3.0 at GCE. 
 
Cyclic voltammetric behaviour of itraconazole 
Here, itraconazole gave a single well-defined peak 
in BR buffer of pH 3.0 with 1 M KCl at GCE and the 
cyclic voltammogram is shown in Figure 3. The sharp 
anodic oxidation peak of itraconazole was observed at 
0.769 V peak potential. No reduction peak was 
observed on the reverse cathodic scan, signifying the 
irreversible nature of the electrochemical reaction
4,30
. 
Also, no peak was obtained in blank (without 
itraconazole) BR buffer of pH 3.0. 
 
Effect of scan rate 
The cyclic voltammograms of itraconazole in BR 
buffer exhibits a well-defined oxidation peak in the 
 
 




Figure 3 — Cyclic voltammograms recorded at GCE with 
itraconazole (Red curve) and without itraconazole or blank  
(Blue curve) 




potential range of 0.2 to 1.0 V vs. Ag/AgCl reference 
electrode at various scan rates 60 to 160 mV/s 
(Figure 4A). The peak potential shifted towards more 
positive values with increasing scan rate following the 
Nicholson theory
4,34
. There was no peak was observed 
in the cathodic direction, suggesting the irreversible 
nature of the electrode process. This behavior 
confirms the irreversible character of the oxidation 
reaction at GCE. Furthermore, linear plots of peak 
current vs. square root of scan rate (Figure 4B) 
following the Ip α ν
1/2
 should be obtained for an 
adsorption controlled process. A linear plot between 
Ip and v
1/2
 indicates about adsorptive nature of 
electrode process. The linear relationship existing 
between peak current (Ip) and square root of the scan 
rate (v
1/2
) with a slope confirms the adsorptive nature 
of oxidation of itraconazole; the linear regression 
equation related to the plot was found as (eq. 1): 
 
Ip (μA) = 3.402 v
1/2
 - 21.50, R² = 0.988 (1) 
 
Here, Figure 4C illustrates a plot between log Ip vs. 
log ν with slope 1.105 log Ip/log v is very near to the 




Furthermore, the linear regression equation related 
to the plot of logarithm of peak current Ip (μA) vs. 
logarithm of scan rate (mV/s) was expressed as (eq. 2): 
 
log Ip = 1.105 log ν – 1.736, R
2 
= 0.996 (2) 
 
Influence of pH 
The influence of the pH on the oxidation process 
was analyzed and a progression of voltammograms 
was observed. Single voltammetric peak was 
observed in the whole pH range (2-6) studied. The 
peak current was also dependent on the pH, implying 
the involvement of the protons in the current-limiting 
electrode process. The maximum peak current value 
for the voltammetric peak (sharp) was obtained at the 
pH 3.0 (Figure 5A); 2.7 mM itraconazole used. 
Moreover, the peak height attains maxima at pH 3.0 
and thereafter decreases (Figure 5B). Therefore, pH 
3.0 was selected as the optimum pH for the study of 
itraconazole. 
The effect of pH reveals the involvement of proton 
in the electrochemical reaction as anodic peak-
potential negatively shifted with increasing pH of the 
solution
4,30
. The peak-potential was found to be 
linearly dependent on pH, plotted in Figure 5C, and 
the corresponding linear regression equation is as 
followeds (eq. 3): 
 
Ep (V) = -0.003 pH + 0.840, R
2
 = 0.905  (3) 
 
The slope of the linear regression equation is -
0.003 V/pH, which is very far from the theoretical 





 in an electrode process
30,31
. 
Herein, the results of the pH study proved that the 
 
 
Figure 4 — (A) CVs at different scan rates 60 to 160 mV/s with 
2.7 mM itraconazole in BR buffer. (B) Plot of Ip vs. v1/2. (C) Plot 
of log Ip vs. log v 




number of electrons and protons are not equally 
participated in the electro-oxidation reaction of 
itraconazole at GCE. 
 
Concentration effect 
To confirm that the peak obtained was solely due 
to the oxidation of itraconazole moiety, cyclic 
voltammograms (CVs) were recorded at various 
concentrations (26.7, 52.9, 78.6, 103.8, 128.6, and 
152.8 µM) at scan rate of 100 mV/s. The peak 
intensity increased with increasing concentration of 
itraconazole as given in Figure 6A. The peak current 
linearly increased with increasing concentration as 
shown in Figure 6B and corresponding linear 
regression equation was found as (eq. 4): 
 
log Ip = 11975 C + 26.39, R
2
 = 0.902 (4) 
 
Possible electro-oxidation mechanism of itraconazole 
On the basis of anodic voltammetric results, it can 




participation/removal in electrochemical 
oxidation reaction of itraconazole at GCE as shown in 




Moreover, the complete mechanism steps are 
explained in our previous research article
30
. Briefly, the 
transformation of piperazine heterocyclic ring to 
tetrahydro-1-pyrazinium heterocyclic ring within 
itraconazole moiety through single-electron transfer 
oxidation and deprotonation mechanism steps. The  
 
 
Figure 5 — (A) CVs recorded at different pH range of BR buffer at 
GCE with itraconazole. (B) Plot of Ip vs. pH. (C) Plot of peak Ep vs. pH 
 
 
Figure 6 — (A) CVs of itraconazole with increasing 
concentrations from 26.7 to 152.8 µM in acidic BR buffer, and 
(B) plot of peak current vs. concentration 




N-radical cation is mainly formed as an intermediate 
species in single-electron transfer oxidative process
35,36
. 
Furthermore, the C-based radical produced from  
C-anion because of the electronegativity (X)-factors of 
N-atom. Eventually, tetrahydro-1-pyrazinium 
heterocyclic ring is formed due to driving force of 
stability over radical or radical cation. 
 
Validation of analytical process 
DPASV and SWASV modes were selected to 
develop an electrochemical method for quantitative 
determination of itraconazole at GCE as it gives 
improved sensitivity with high speed of current 
potential curves. According to the obtained results, it 
was possible to apply this technique to the 
quantitative analysis of itraconazole in bulk form. The 
validity of the proposed method was assessed by 
studying the analytical parameters through DPASVs 
plus SWASVs.  
 
Limit of detection (LOD) and limit of 
quantification (LOQ) were calculated, and the results 
are tabulated in Table I. LOD and LOQ were 
calculated according to the following equations
4,34
: 
LOD = 3s/m and LOQ = 10 s/m; Where s = standard 
deviation, m = slope of linearity. 
 
Under the optimized condition a linear correlation 
between DPASV and SWASV peak intensity; and the 
drug concentration was obtained over the range 
between 26.7 and 152.8 µM, DPASVs and SWASVs 
were recorded (Figure 7A and Figure 8A). Calibration 
plot of Ip vs. C as graphed in Figure 7B and Figure 8B 
and their corresponding calibration equations can be 
written as (eq. 5,6): 
 
 
Scheme I — Possible mechanism of itraconazole 
 
Table I — The regression parameters obtained from calibration curves for quantitative determination of itraconazole by DPASV and 
SWASV techniques in acidic BR buffer 
Analytical Parameter DPASV SWASV 
Potential range 0.2-1.0 V 0.2-1.0 V 
Linearity range 26.7-103.8 µM 26.7-152.8 µM 
Slope 17458 µA/M 14318 µA/M 
Correlation coefficient (R2) 0.965 0.945 
RSD 0.32% 9.16% 
LOD 27.28 µM 33.82 µM 
LOQ 90.93 µM 112.75 µM 
Note: Mean values were calculated by three independent repeated measurements. 




DPASV: Ip (μA) = 17458 C + 49.65, R
2
 = 0.965 (5) 
 
SWASV: Ip (μA) = 14318 C + 1.746, R
2
 = 0.945 (6) 
 
Conclusions 
In summary, a simple and cost-effective method for 
itraconazole detection was employed as voltammetric 
techniques in acidic media at GCE. The 
electrochemical oxidation of itraconazole under the 
conditions described is an irreversible process 
controlled by adsorption. A validated differential 
pulse and square wave anodic stripping voltammetric 
path was developed and successfully applied to the 
quantification of itraconazole in bulk form. Stripping 
technique is one of the best-known analytical 
methods. This is justified as the results havebeen 
acquired from the analysis of moiety with low detection 
limits. This technique has the advantage of acceptable 
low detection limits, and suitable for the routine 
determination of the drug in quality control laboratories. 
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